Chemours (CC) PT Lowered to $13 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CC Hot Sheet
Price: $13.79 +5.35%
Rating Summary:
7 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
7 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
JPMorgan analyst Jeffrey Zekauskas lowered the price target on Chemours (NYSE: CC) to $13.00 (from $15.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Chemours (CC) PT Lowered to $15 at UBS
- Arm Holdings (ARM) PT Lowered to $215 at HSBC
- Bayerische Motoren Werke AG (BMW:GR) (BMWYY) PT Lowered to EUR66 at HSBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
